Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study

<div>Rates of hospitalization due to RSV infection and compliance to palivizumab across (2012-2013, 2013-2014, 2014-2015, 2015-2016, and 2016-2017) seasons. RSV, respiratory syncytial virus; LRTI, lower respiratory tract infection.</div>

Canadian Respiratory Journal

fig3

Figure 3

Figure 3: Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study 

Figure 3 | Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study 